 |
Madrigal Pharmaceuticals
Last updated: September 15, 2024
Madrigal leaders: Drs. Paul Friedman and Rebecca Taub
USA | Funding: $1.6B (+)
Website: http://madrigalpharma.com/
The Company is targeting treatment of both niche and prevalent indications, including fatty liver disease.
Website: http://madrigalpharma.com/
The Company is targeting treatment of both niche and prevalent indications, including fatty liver disease.
